Table 4 Treatment characteristics
Treatment, n = 142 | Value | P value |
|---|---|---|
NACT, n (%) | 142 | ≤ 0.001 |
 TEC | 48 (33.8%) |  |
 EC-T | 86 (60.6%) |  |
 TAC | 8 (5.6%) |  |
Endocrine therapy, n (%) |  | ≥ 0.05 |
 Yes | 90 (63.4%) |  |
 No | 52 (36.6%) |  |
Trastuzumab treatment, n (%) |  | ≥ 0.05 |
 Yes | 28 (19.7%) |  |
 No | 114 (80.3%) |  |
Surgical, n (%) | 137 (96.5%) | ≤ 0.001 |
Rejection surgery, n | 5 | Â |
Death, n | 5 | ≤ 0.001 |
Survival, n | 137 | Â |